Your browser doesn't support javascript.
loading
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer.
Oxnard, G R; Yang, J C-H; Yu, H; Kim, S-W; Saka, H; Horn, L; Goto, K; Ohe, Y; Mann, H; Thress, K S; Frigault, M M; Vishwanathan, K; Ghiorghiu, D; Ramalingam, S S; Ahn, M-J.
Afiliação
  • Oxnard GR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address: geoffrey_oxnard@dfci.harvard.edu.
  • Yang JC; Department of Oncology, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.
  • Yu H; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
  • Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Saka H; Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
  • Horn L; Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, USA.
  • Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Mann H; AstraZeneca R&D, Cambridge, UK.
  • Thress KS; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Boston, USA.
  • Frigault MM; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca, Boston, USA.
  • Vishwanathan K; Clinical Pharmacology and Safety Science, R&D, AstraZeneca, Boston, USA.
  • Ghiorghiu D; AstraZeneca R&D, Cambridge, UK.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Emory University, Winship Cancer Institute, Atlanta, USA.
  • Ahn MJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ann Oncol ; 31(4): 507-516, 2020 04.
Article em En | MEDLINE | ID: mdl-32139298

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article